OTC · Financial Statements
Oxford BioDynamics Plc (OXBOF) Financial Statements
$0.00
OTC: OXBOF
Market Cap $5.33M
Overview Financials Dividend
Oxford BioDynamics Plc most recently reported annual revenue of $1.0M, a net loss of $11.0M. See the full income statement, balance sheet, and cash flow statement below, plus valuation and return ratios.
Annual Financials (USD)
Metric 2021 2022 2023 2024 2025
Revenue $0 $0 $1.0M $1.0M $1.0M Operating Profit $-8.0M $-9.0M $-10.0M $-13.0M $-11.0M Net Profit $-7.0M $-7.0M $-11.0M $-12.0M $-11.0M EPS $-0.07 $-0.07 $-0.07 $-0.04 $-0.01 Op Margin -2202.9% -5585.1% -1993.7% -2027.4% -1011.3%
Balance Sheet (USD)
Metric 2021 2022 2023 2024 2025
Total Assets $15.0M $11.0M $16.0M $12.0M $8.0M Total Liabilities $9.0M $9.0M $10.0M $8.0M $7.0M Cash $2.0M $1.0M $5.0M $2.0M $1.0M Borrowings $7.0M $6.0M $6.0M $6.0M $5.0M
Cash Flow (USD)
Metric 2021 2022 2023 2024 2025
Operating Cash Flow $-6.0M $-5.0M $-8.0M $-10.0M $-8.0M Investing Cash Flow $0 $0 $-1.0M $-2.0M $1.0M Financing Cash Flow $0 $0 $-1.0M $-1.0M $-1.0M Net Cash Flow $-4.0M $-1.0M $4.0M $-3.0M $-1.0M Free Cash Flow $-9.0M $-6.0M $-9.0M $-11.0M $-8.0M
Valuation & Return Ratios
Metric Value PEG Ratio 0.00 EV / EBITDA -0.50 FCF Yield -274.08% Quick Ratio 1.89 Interest Coverage -32.55 Return 1Y -50.00% Return 3Y -99.58% Return 5Y —
Data for information only, not investment advice. Figures may be delayed or inaccurate; verify against company filings. See our disclaimer .